Sickle cell disease (SCD) results from the homozygous state of the mutation, or a compound heterozygous state with one of structural variants of Hb D-Punjab, Hb O-Arab, Hb C, or β-thalassemia mutation in the other β-genes [16, 17]. This evidence concerns the gene GSTM1 and Schnyder corneal dystrophy.